###begin article-title 0
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Cofilin activation in peripheral CD4 T cells of HIV-1 infected patients: a pilot study
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 447 456 447 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 761 769 761 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 260 265 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 566 571 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 581 589 <span type="species:ncbi:9606">patients</span>
###xml 646 654 <span type="species:ncbi:9606">patients</span>
###xml 803 808 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 820 825 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cofilin is an actin-depolymerizing factor that regulates actin dynamics critical for T cell migration and T cell activation. In unstimulated resting CD4 T cells, cofilin exists largely as a phosphorylated inactive form. Previously, we demonstrated that during HIV-1 infection of resting CD4 T cells, the viral envelope-CXCR4 signaling activates cofilin to overcome the static cortical actin restriction. In this pilot study, we have extended this in vitro observation and examined cofilin phosphorylation in resting CD4 T cells purified from the peripheral blood of HIV-1-infected patients. Here, we report that the resting T cells from infected patients carry significantly higher levels of active cofilin, suggesting that these resting cells have been primed in vivo in cofilin activity to facilitate HIV-1 infection. HIV-1-mediated aberrant activation of cofilin may also lead to abnormalities in T cell migration and activation that could contribute to viral pathogenesis.
###end p 2
###begin title 3
Findings
###end title 3
###begin p 4
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 305 310 <span type="species:ncbi:9606">human</span>
Cofilin is a member of the actin-depolymerizing factor (ADF) family of proteins [1] that play a central role in regulating actin dynamics [2,3]. The actin-severing and depolymerization activities of cofilin are essential in controlling cell polarity [4], cell motility [5] and cell division [6,7]. In the human immune system, cofilin has also been implicated in two hallmark activities of T cells, namely chemotaxis and T cell activation [8]. In chemotaxis, directed cell movement towards chemoattractants is controlled by localized cortical actin polymerization and depolymerization, and cofilin is the driving force for promoting the cortical actin dynamics [9]. In antigen-specific T cell activation the reorganization of the cortical actin plays a critical role in the formation of the immunological synapse. Engagement of CD2 or CD28 receptors but not TCR results in cofilin activation and its association with the actin cytoskeleton [10]. Peptides that block cofilin binding to actin result in severe defects in T cell activation [11].
###end p 4
###begin p 5
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 498 500 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
Cofilin activity is regulated through phosphorylation and dephosphorylation at serine-3 by the simultaneous actions of cofilin kinases and phosphatases [12-14]. Phosphorylated cofilin is unable to bind to F-actin; thus cofilin is inactivated by phosphorylation and activated by dephosphorylation [13,14]. The direct upstream kinases that inactivate cofilin are the LIM kinases (LIMK1 and LIMK2) [15,16], whereas several serine phosphatases such as slingshot, chronophin [17,18], PP1alpha and PP2A [19] dephosphorylate and activate cofilin.
###end p 5
###begin p 6
###xml 14 16 14 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 30 32 30 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 449 454 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Recently, we [20] and others [21] have demonstrated that in unstimulated resting CD4 T cells purified from the peripheral blood, cofilin exists largely as the phosphorylated form, implying that in the absence of chemotactic stimulation or T cell activation, cofilin is largely inactive. We have also suggested that this restricted cofilin activity in resting T cells inhibits the cortical actin dynamics, hindering viral post-entry migration. Thus, HIV-1 hijacks chemokine receptor signalling through CXCR4 to trigger the activation of cofilin. This process increases the cortical actin dynamics, facilitating viral nuclear migration [20,22].
###end p 6
###begin p 7
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1278 1280 1278 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1461 1463 1461 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 264 267 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 309 314 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 741 744 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 964 967 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1051 1054 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Given the fact that in infected patients, CD4 T cells are chronically exposed to gp120, we decided to investigate the outcome of persistent gp120 stimulation on cofilin phosphorylation. To address this question, we initially used resting CD4 T cells purified from HIV negative donors and stimulated them with HIV-1 or gp120 for extended periods of time. We incubated cells with the virus for several hours up to 24 hours instead of minutes. Persistent stimulation of a receptor has been known to affect down-stream targets differently than transient stimulation [23]. As shown in Figure 1A, we observed cycles of cofilin phosphorylation and dephosphorylation with the prolonged treatment. These data suggest that persistent stimulation with HIV will likely have a lasting impact on the cofilin activity. We also repeated this experiment using purified gp120 and observed persistent cofilin dephosphorylation (Figure 1B). The variation in cofilin responses between HIV particles and gp120 may be related to differences in dosage or gp120 conformation. HIV particles carry the gp120 trimer on the surface, whereas the purified gp120 protein we used is a monomer. This is reminiscent of the CD40 ligand (CD40L) in its distinctive signalling properties as a trimer or as a monomer [24]. The strength and persistence of CD40L stimulation dictate the capacity of dendritic cells either to migrate to draining lymph nodes or to secrete locally inflammatory cytokines [24].
###end p 7
###begin p 8
###xml 54 63 54 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Activation of cofilin in resting CD4 T cells cultured <italic>in vitro </italic>and stimulated with HIV-1 and gp120</bold>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 342 347 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activation of cofilin in resting CD4 T cells cultured in vitro and stimulated with HIV-1 and gp120. Resting CD4 T cells were purified from uninfected donors by antibody-mediated negative depletion using Dynalbeads as previously described [20]. Cells were cultured overnight in the absence of cytokines or activation, and then stimulated with HIV-1 (10 ng p24) (A) or with gp120 (50 nM) for various times at 37degreesC as indicated. Stimulated cells were lysed and analyzed by western blot using antibodies against the phosphorylated cofilin (P-cofilin) or total cofilin or GAPDH for controls.
###end p 8
###begin p 9
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 893 894 893 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1087 1089 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1198 1199 1198 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1211 1212 1211 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1221 1230 1221 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p = 0.002</italic>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1255 1257 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1469 1471 1469 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1480 1482 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 1864 1866 1864 1866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 1887 1889 1887 1889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 2448 2449 2448 2449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 2487 2489 2487 2489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 2666 2668 2666 2668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 3170 3179 3170 3179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 3180 3182 3180 3182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 3488 3497 3488 3497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 3504 3506 3504 3506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 117 122 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 132 140 <span type="species:ncbi:9606">patients</span>
###xml 263 271 <span type="species:ncbi:9606">patients</span>
###xml 473 476 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 599 604 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1108 1111 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1121 1129 <span type="species:ncbi:9606">patients</span>
###xml 1195 1198 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1208 1211 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1570 1575 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1585 1593 <span type="species:ncbi:9606">patients</span>
###xml 1669 1674 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1684 1692 <span type="species:ncbi:9606">patients</span>
###xml 1794 1802 <span type="species:ncbi:9606">patients</span>
###xml 1830 1833 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1992 1997 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2182 2190 <span type="species:ncbi:9606">patients</span>
###xml 2333 2341 <span type="species:ncbi:9606">patients</span>
###xml 2738 2746 <span type="species:ncbi:9606">patients</span>
###xml 2849 2854 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2890 2897 <span type="species:ncbi:9606">patient</span>
Based on these results, we also hypothesized that activation of cofilin may also occur in the resting CD4 T cells of HIV-1-infected patients, considering that these resting T cells are chronically exposed to gp120 during the course of infection, and that even in patients on HAART, latently infected cells persist and low levels of viral replication take place [25-27]. Additionally, the threshold for coreceptor activation of signalling has been shown to be as few as two HIV virion particles [28]. Thus, we set up a small-scale pilot study to probe cofilin activity in resting cells purified from HIV-1-infected and uninfected subjects. Peripheral blood resting CD4 T cells from eight infected (Additional file 1) and ten uninfected subjects were purified by negative depletion, unstimulated and then analyzed by immunoblotting for both phospho-cofilin and total cofilin. As shown in Figure 2, in the resting CD4 T cells of uninfected subjects, cofilin exists primarily in its inactive phosphorylated form in the absence of chemotactic stimulation or T cell activation [20,21] (Figure 2C). In contrast, in HIV positive patients, significantly lower ratios of phospho-cofilin to total cofilin (HIV-, 1.142; HIV+, 0.535; p = 0.002) (Figures 2A and Figure 2B) were observed, suggesting a significant shift towards cofilin activation. These results were further confirmed by NEPHGE-western blot to measure the absolute ratio of phospho-cofilin to active cofilin (Figures 2C, Figure 2D). Again, we observed considerably lower ratios of phospho-cofilin to active cofilin in HIV-1-infected patients, confirming the upregulation of cofilin activity in resting CD4 T cells of HIV-1-infected patients. Given the great extent of cofilin activation and the fact that a majority of resting CD4 T cells in patients are not infected (0.2-16.4 HIV-latently infected cells per 106 resting CD4 T cells [29]), these data imply a global activation of cofilin in resting CD4 T cells, not just those infected by HIV-1. Therefore, indirect mechanisms, such as contact with viral or cell-free gp120 or chronic immune activation, may be responsible for the activation of cofilin in resting CD4 T cells in patients. Importantly, the cofilin activation observed is not a result of general T cell activation, since the population of CD4 T cells purified from patients is quiescent, judged by the lack of activation markers such as HLA-DR or CD69 on the cell surface (Figure 3), similar to a previous observation [30]. This also appears to be consistent with our previous demonstration that although stimulation with gp120 can trigger cofilin activation, it does not activate resting T cells [20]. Our data also demonstrate that in the peripheral blood of infected patients, resting CD4 T cells have largely been altered or primed, at least in cofilin activity, to facilitate HIV-1 infection. Nevertheless, the small patient population as well as lack of multiple controls and long-term follow up studies did not permit us to conclude that the cofilin activation observed is necessarily the result of chronic gp120 exposure, although gp120 has a demonstrated ability to trigger cofilin activation in vitro [20]. Further large-scale studies are needed to address this correlation and other critical questions such as the possible relationship between cofilin activation and disease progression. Future studies are also required to determine whether the status of cofilin correlates with drug treatment. Our previous in vitro study [20] and this small-scale pilot investigation certainly serve as a rationale for future clinical studies.
###end p 9
###begin p 10
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Activation of cofilin in resting CD4 T cells of HIV-1-infected patients</bold>
###xml 576 578 576 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">0.002</italic>
###xml 724 726 724 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 728 733 728 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">0.002</italic>
###xml 1202 1204 1202 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 189 194 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 467 472 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 482 490 <span type="species:ncbi:9606">patients</span>
###xml 1271 1276 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1301 1306 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activation of cofilin in resting CD4 T cells of HIV-1-infected patients. (A) Resting CD4 T cells were purified by antibody-mediated negative depletion using Dynalbeads. Cells purified from HIV-1-infected and uninfected donors were cultured overnight in the absence of cytokines or activation, and then lysed and analyzed by western blot using antibodies against P-cofilin or total cofilin. The relative ratios of P-cofilin to total cofilin were measured and plotted. HIV-1-infected patients had statistically-significant lower ratios of P-cofilin/cofilin (0.535 versus 1.142, p = 0.002), suggesting higher levels of active cofilin. For statistic analysis, a two-tailed Student's t-test on the means resulted in a p-value of p = 0.002. At a pre-determined significance level of 0.05, this shows that the difference in the mean ratios of the two sample groups is statistically significant. A standard power computation showed that the t-test was very well powered (95.2%) for this study. (B) Shown are the longer exposures of the western blots used in (A). The results were confirmed by NEPHGE-western blot to directly separate P-cofilin to active cofilin, and then probed with an anti-cofilin antibody [20]. Shown are the absolute ratios of P-cofilin to active cofilin in HIV-1 negative donors (C) and HIV-1-infected donors (D).
###end p 10
###begin p 11
###xml 0 126 0 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lack of detection of T cell activation markers on the surface of resting CD4 T cells from HIV-1-infected and uninfected donors</bold>
###xml 796 797 796 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 869 870 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 90 95 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 240 245 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 478 483 <span type="species:ncbi:9606">human</span>
###xml 643 648 <span type="species:ncbi:9606">human</span>
###xml 773 776 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 793 796 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 844 849 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 866 869 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Lack of detection of T cell activation markers on the surface of resting CD4 T cells from HIV-1-infected and uninfected donors. Resting CD4 T cells were purified by antibody-mediated negative depletion using Dynalbeads. Cells purified from HIV-1-infected and uninfected donors were cultured overnight in the absence of cytokines or activation, and then stained for surface expression of HLA-DR or CD69. Shown are flow cytometry analyses of cells stained with a PE-labelled anti-human HLA-DR antibody (A and C, right panel) or a similarly labelled isotype control antibody (A and C, left panel). Cells were also stained with a PE-labelled anti-human CD69 antibody (B and D, right panel) or a similarly labelled isotype control antibody (B and D, left panel). Cells from the HIV negative donor (HIV-) were used in (A) and (B), and cells from the HIV-1-infected donor (HIV+) were used in (C) and (D).
###end p 11
###begin p 12
###xml 400 401 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 766 768 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 769 771 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 953 955 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
HIV-1-mediated aberrant activation of cofilin in resting CD4 T cells may affect normal T cell migration and T cell activation. In the human immune system, cofilin is directly involved in chemotaxis and T cell activation. For example, cofilin was shown to affect SDF1alpha-driven T cell chemotaxis, and blocking cofilin phosphorylation diminishes actin reorganization and normal chemotactic response [9]. During T cell activation, cofilin is activated by co-stimulation signals to mediate cortical actin reorganization, which plays a critical role in the formation and stabilization of the immunological synapse. It is commonly known that genetic defects affecting actin activity by means of a deficiency in signaling molecules, such as WASP, cause immunodeficiency [31,32]. It would not be a surprise if cofilin dysregulation also results in T cell-mediated immunodeficiencies, given the central role of cofilin in regulating actin dynamics in T cells [33].
###end p 12
###begin p 13
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 213 218 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
###xml 708 713 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 714 722 <span type="species:ncbi:9606">patients</span>
###xml 1171 1179 <span type="species:ncbi:9606">patients</span>
The demonstration of cofilin activation in resting CD4 T cells of HIV-1-infected patients offers new avenues for investigation into viral pathogenesis. It has long been recognized that the residual CD4 T cells in HIV-1-infected patients have numerous functional abnormalities, such as loss of T helper function [34], T cell anergy [35,36], increased T cell proliferation [37] and abnormal T cell homing and migration [38,39]. These T cell defects largely result from a bystander effect [40]. It remains to be determined whether some of these abnormalities are directly linked to aberrant activation of cofilin in resting CD4 T cells. Additionally, as shown in this pilot study, the peripheral CD4 T cells in HIV-1 patients strikingly resemble the migratory T lymphoma cells in terms of carrying active cofilin [21,41]. It is likely that these CD4 T cells also have abnormal migratory behaviours associated with aberrant cofilin activation. It remains unknown whether migratory abnormalities could contribute to the eventual destruction of T cells in lymph nodes or tissues. Finally, the identification of cofilin as a critical molecule in resting CD4 T cells of infected patients may serve as a diagnostic marker to reflect alterations of T cell function in disease progression.
###end p 13
###begin title 14
Abbreviations
###end title 14
###begin p 15
###xml 150 155 <span type="species:ncbi:9606">Human</span>
LIMK1: LIM Domain Kinase 1; TCR: T Cell Receptor; HAART: Highly Active Antiretroviral Therapy; NEPHGE: Nonequilibrium pH Gel Electrophoresis; HLA-DR: Human Leukocyte Antigen-DR; WASP: Wiskott-Aldrich Syndrome Protein; SDF1alpha: Stromal-Cell-Derived Factor 1alpha.
###end p 15
###begin title 16
Competing interests
###end title 16
###begin p 17
The authors declare that they have no competing interests.
###end p 17
###begin title 18
Authors' contributions
###end title 18
###begin p 19
###xml 207 210 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
YW conceived of the study, supervised blood donation, performed T cell purification and wrote the manuscript. AY, DY, WW, and JL performed cell purification, western blot, and analysis. TB and DW supervised HIV+ donor recruiting and testing. KS performed statistical analyses.
###end p 19
###begin title 20
Supplementary Material
###end title 20
###begin title 21
Additional file 1
###end title 21
###begin p 22
Click here for file
###end p 22
###begin title 23
Acknowledgements
###end title 23
###begin p 24
We thank the George Mason University (GMU) Student Health Center and the GMU and Chesapeake Bay Institutional Review Boards. AY was supported by the National Defense Science and Engineering Fellowship. This work was supported by GMU and by Public Health Service grant AI069981 from NIAID to YW.
###end p 24
###begin article-title 25
Partial purification and characterization of an actin depolymerizing factor from brain
###end article-title 25
###begin article-title 26
Cofilin promotes rapid actin filament turnover in vivo
###end article-title 26
###begin article-title 27
Proteins of the ADF/cofilin family: essential regulators of actin dynamics
###end article-title 27
###begin article-title 28
ADF/cofilin controls cell polarity during fibroblast migration
###end article-title 28
###begin article-title 29
Actin depolymerizing factor (ADF/cofilin) enhances the rate of filament turnover: implication in actin-based motility
###end article-title 29
###begin article-title 30
Studying the effects of actin cytoskeletal destabilization on cell cycle by cofilin overexpression
###end article-title 30
###begin article-title 31
###xml 0 14 <span type="species:ncbi:8355">Xenopus laevis</span>
Xenopus laevis actin-depolymerizing factor/cofilin: a phosphorylation-regulated protein essential for development
###end article-title 31
###begin article-title 32
Actin cytoskeletal dynamics in T lymphocyte activation and migration
###end article-title 32
###begin article-title 33
Stromal cell-derived factor 1alpha activates LIM kinase 1 and induces cofilin phosphorylation for T-cell chemotaxis
###end article-title 33
###begin article-title 34
Cofilin: a missing link between T cell co-stimulation and rearrangement of the actin cytoskeleton
###end article-title 34
###begin article-title 35
Cofilin peptide homologs interfere with immunological synapse formation and T cell activation
###end article-title 35
###begin article-title 36
Isolation and characterization of a regulated form of actin depolymerizing factor
###end article-title 36
###begin article-title 37
Reactivation of phosphorylated actin depolymerizing factor and identification of the regulatory site
###end article-title 37
###begin article-title 38
###xml 104 126 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Xenopus actin depolymerizing factor/cofilin (XAC) is responsible for the turnover of actin filaments in Listeria monocytogenes tails
###end article-title 38
###begin article-title 39
Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization
###end article-title 39
###begin article-title 40
Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase
###end article-title 40
###begin article-title 41
Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin
###end article-title 41
###begin article-title 42
Chronophin, a novel HAD-type serine protein phosphatase, regulates cofilin-dependent actin dynamics
###end article-title 42
###begin article-title 43
###xml 102 107 <span type="species:ncbi:9606">human</span>
The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes
###end article-title 43
###begin article-title 44
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells
###end article-title 44
###begin article-title 45
###xml 26 31 <span type="species:ncbi:9606">human</span>
Costimulatory signals for human T-cell activation induce nuclear translocation of pp19/cofilin
###end article-title 45
###begin article-title 46
How to engage Cofilin
###end article-title 46
###begin article-title 47
###xml 53 58 <span type="species:ncbi:9606">human</span>
Persistent tumor necrosis factor signaling in normal human fibroblasts prevents the complete resynthesis of I kappa B-alpha
###end article-title 47
###begin article-title 48
Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells
###end article-title 48
###begin article-title 49
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
###end article-title 49
###begin article-title 50
###xml 71 76 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication
###end article-title 50
###begin article-title 51
###xml 13 48 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy
###end article-title 51
###begin article-title 52
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Physiological levels of virion-associated human immunodeficiency virus type 1 envelope induce coreceptor-dependent calcium flux
###end article-title 52
###begin article-title 53
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [see comments]
###end article-title 53
###begin article-title 54
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 78 81 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV envelope induces virus expression from resting CD4+ T cells isolated from HIV-infected individuals in the absence of markers of cellular activation or apoptosis
###end article-title 54
###begin article-title 55
Isolation of a novel gene mutated in Wiskott-Aldrich syndrome
###end article-title 55
###begin article-title 56
Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization
###end article-title 56
###begin article-title 57
ADF/cofilin and actin dynamics in disease
###end article-title 57
###begin article-title 58
###xml 83 111 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 125 133 <span type="species:ncbi:9606">patients</span>
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging
###end article-title 58
###begin article-title 59
###xml 36 64 <span type="species:ncbi:12721">human immunodeficiency virus</span>
CD4+ lymphocyte function with early human immunodeficiency virus infection
###end article-title 59
###begin article-title 60
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling
###end article-title 60
###begin article-title 61
###xml 10 15 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 119 122 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 132 140 <span type="species:ncbi:9606">patients</span>
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients
###end article-title 61
###begin article-title 62
###xml 28 31 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The potential importance of HIV-induction of lymphocyte homing to lymph nodes
###end article-title 62
###begin article-title 63
###xml 62 97 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Migration of antigen-specific T cells away from CXCR4-binding human immunodeficiency virus type 1 gp120
###end article-title 63
###begin article-title 64
Induction of bystander T cell proliferation by viruses and type I interferon in vivo
###end article-title 64
###begin article-title 65
Inhibition of constitutive serine phosphatase activity in T lymphoma cells results in phosphorylation of pp19/cofilin and induces apoptosis
###end article-title 65

